SWEDISH ORPHAN BIOVITRUM AS
976313682ActiveGlobal biopharma company developing innovative treatments for rare diseases.
Biopharmaceutical Companysobi.no
Yleiskatsaus
- 7
- Työntekijät
- 35.7milj NOK
- Liikevaihto
- 1996
- Perustettu
Avainpäättäjät
Iris Loew-Friedrich
Board member
@sobi.com
Zlatko Rihter
Board member
@sobi.com
Daniel Rankin
Head of Strategy & Corporate Development
@sobi.com
Norbert Oppitz
Head of International
@sobi.com
+22 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Sobi, officially Swedish Orphan Biovitrum AB, is a global biopharmaceutical company dedicated to rare diseases. Its core mission is to develop and ensure access to innovative treatments that significantly transform the lives of individuals living with these conditions. The organization concentrates...